Moat Ross
SEC insider (Form 3/4/5 filer). CIK 0001857177. CHIEF OPERATING OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 71 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in LONDON.
Companies Moat Ross has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF OPERATING OFFICER
Moat Ross
CIK: 0001857177
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (71 total)
- Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.5K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect4K shares at avg. $79.28$318K - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
37K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.5K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
9.3K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect1.7K shares- - Apr 9, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect1.7K shares at avg. $46.69$80K - Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.5K shares- - Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect774 shares at avg. $48.94$38K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,457 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,611 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 4,007 | $79.28 | $317,675 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 36,950 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,477 | - | $0 | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 9,250 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 1,740 | - | $0 | Direct |
| Apr 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,703 | $46.69 | $79,513 | Direct |
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,477 | - | $0 | Direct |
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 774 | $48.94 | $37,880 | Direct |
1-10 of 71 transactions